FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose Treatment

FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose Treatment

Source: 
RAPS.org
snippet: 

Teva Pharmaceuticals USA snagged US Food and Drug Administration (FDA) final approval for the first generic naloxone hydrochloride nasal spray known as Narcan, the agency announced on Friday.